Previous close | 0.2000 |
Open | N/A |
Bid | 0.0000 |
Ask | 0.3000 |
Strike | 90.00 |
Expiry date | 2024-07-19 |
Day's range | 0.2000 - 0.2000 |
Contract range | N/A |
Volume | |
Open interest | 10 |
Zimmer Biomet Holdings, Inc. ( NYSE:ZBH ) is about to trade ex-dividend in the next 3 days. The ex-dividend date is one...
With the growing influence of GenAI in the MedTech sector, innovators like ZBH, GEHC and MDT are poised to thrive.
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdikar, President, Chief Executive Officer and a member of the board of directors of Embecta Corp. (embecta), has been appointed to the Zimmer Biomet Board, effective immediately. embecta (Nasdaq: EMBC), formerly part of Becton, Dickinson and Company (BD), is one of the largest pure-play diabetes management companies in the world.